Mesa Laboratories Inc (MLAB)
116.04
-1.07
(-0.91%)
USD |
NASDAQ |
May 10, 16:00
115.79
-0.25
(-0.22%)
After-Hours: 20:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 625.93M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -26.73% |
Valuation | |
PE Ratio | 682.59 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 2.935 |
Price to Book Value | 1.553 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | 0.16 |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.5781 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 74.40% |
Profile
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign. |
URL | https://www.mesalabs.com |
Investor Relations URL | https://investors.mesalabs.com |
HQ State/Province | Colorado |
Sector | Health Care |
Industry | Life Sciences Tools & Services |
Equity Style | Small Cap/Blend |
Next Earnings Release | May. 24, 2024 (est.) |
Last Earnings Release | Feb. 05, 2024 |
Next Ex-Dividend Date | May. 31, 2024 |
Last Ex-Dividend Date | Feb. 28, 2024 |
Ratings
Profile
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign. |
URL | https://www.mesalabs.com |
Investor Relations URL | https://investors.mesalabs.com |
HQ State/Province | Colorado |
Sector | Health Care |
Industry | Life Sciences Tools & Services |
Equity Style | Small Cap/Blend |
Next Earnings Release | May. 24, 2024 (est.) |
Last Earnings Release | Feb. 05, 2024 |
Next Ex-Dividend Date | May. 31, 2024 |
Last Ex-Dividend Date | Feb. 28, 2024 |